Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in patients with delayed thrombocytopenia after stem cell transplantation
2011-004608-39Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of eltrombopag in Thrombocytopenia, sponsored by GIMEMA. Primary endpoint: Overall platelet response rate at two months. Started Mar 2013; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on 2011-004608-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004608-39.